Gyl Financial Synergies, LLC Merck & Co., Inc. Transaction History

Gyl Financial Synergies, LLC

$1.31 Billion
Q3 2024

A detailed history of Gyl Financial Synergies, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 43,908 shares of MRK stock, worth $4.38 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

43,908

Previous 65,176 32.63%

Holding current value

$4.38 Million

Previous $8.07 Million 38.2%

% of portfolio

0.38%

Previous 0.63%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$111.15 - $128.97 $2.36 Million - $2.74 Million	-21,268 Reduced 32.63%	43,908 $4.99 Million
Q2 2024 Jul 23, 2024	BUY	$123.8 - $132.96 $470,935 - $505,779	3,804 Added 6.2%	65,176 $8.07 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $847,261 - $987,249	7,482 Added 13.88%	61,372 $8.1 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $133,439 - $145,214	-1,332 Reduced 2.41%	53,890 $5.88 Million
Q3 2023 Nov 06, 2023	SELL	$102.95 - $114.33 $8.23 Million - $9.14 Million	-79,915 Reduced 59.14%	55,222 $5.69 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.71 Million - $1.87 Million	15,775 Added 13.22%	135,137 $15.6 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $10.8 Million - $12 Million	104,540 Added 705.3%	119,362 $12.7 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $559,703 - $717,616	-6,401 Reduced 30.16%	14,822 $1.64 Million
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $7,692 - $8,641	91 Added 0.43%	21,223 $1.83 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $56,773 - $64,355	680 Added 3.32%	21,132 $1.93 Million
Q1 2022 May 05, 2022	SELL	$73.51 - $82.4 $143,050 - $160,350	-1,946 Reduced 8.69%	20,452 $1.68 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $714,993 - $895,621	9,892 Added 79.1%	22,398 $1.72 Million
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $1,075 - $1,182	-15 Reduced 0.12%	12,506 $939,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $105,324 - $116,499	1,498 Added 13.59%	12,521 $974,000
Q1 2021 May 04, 2021	BUY	$68.86 - $81.11 $437,536 - $515,372	6,354 Added 136.09%	11,023 $850,000
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $86,913 - $96,456	-1,211 Reduced 20.6%	4,669 $382,000
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $130,919 - $148,397	1,789 Added 43.73%	5,880 $488,000
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $9,577 - $10,897	136 Added 3.44%	4,091 $316,000
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $2,471 - $3,424	-39 Reduced 0.98%	3,955 $304,000
Q4 2019 Feb 06, 2020	SELL	$77.58 - $87.54 $57,486 - $64,867	-741 Reduced 15.65%	3,994 $363,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $163,724 - $178,465	2,152 Added 83.31%	4,735 $399,000
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $5,796 - $6,771	83 Added 3.32%	2,583 $217,000
Q1 2019 May 21, 2019	SELL	$69.58 - $79.36 $1.58 Million - $1.81 Million	-22,761 Reduced 90.1%	2,500 $208,000
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $1.76 Million - $2 Million	25,261 New	25,261 $2.1 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.

Account

Gyl Financial Synergies, LLC Merck & Co., Inc. Transaction History